Next Step On the Innovation Pathway: Renal Disease Devices
This article was originally published in The Gray Sheet
Executive Summary
FDA issued an “innovation challenge” Jan. 12 asking companies developing devices for end-stage renal disease to volunteer for a pilot program designed to assess new statistical tools and collaborative processes that the agency hopes will accelerate product development.